80 related articles for article (PubMed ID: 5753734)
1. [Study on the fiber connection of the substantia nigra].
Masuda S
Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):839-44. PubMed ID: 5753734
[No Abstract] [Full Text] [Related]
2. The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.
Gibb WR; Fearnley JM; Lees AJ
Adv Neurol; 1990; 53():31-4. PubMed ID: 2173373
[No Abstract] [Full Text] [Related]
3. Iron and ferritin in substantia nigra in Parkinson's disease.
Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D
Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142
[No Abstract] [Full Text] [Related]
4. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
[TBL] [Abstract][Full Text] [Related]
5. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
Hill WD; Arai M; Cohen JA; Trojanowski JQ
J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
[TBL] [Abstract][Full Text] [Related]
6. Iron in the Parkinsonian substantia nigra.
Gerlach M; Double K; Riederer P; Hirsch E; Jellinger K; Jenner P; Trautwein A; Youdim MB
Mov Disord; 1997 Mar; 12(2):258-60. PubMed ID: 9087993
[No Abstract] [Full Text] [Related]
7. An altered histaminergic innervation of the substantia nigra in Parkinson's disease.
Anichtchik OV; Rinne JO; Kalimo H; Panula P
Exp Neurol; 2000 May; 163(1):20-30. PubMed ID: 10785440
[TBL] [Abstract][Full Text] [Related]
8. [Histological study on the intranuclear inclusions of the melanin-pigmented cells of the substantia nigra (supplement: on the intranuclear inclusions of the nerve cells of the loci cerulei). 2].
Anraku S; Fukutomi T; Naganuma R
No To Shinkei; 1970 Sep; 22(9):1055-9. PubMed ID: 5536078
[No Abstract] [Full Text] [Related]
9. Ultrastructural observations in Parkinsonism.
Roy S; Wolman L
J Pathol; 1969 Sep; 99(1):39-44. PubMed ID: 5359222
[No Abstract] [Full Text] [Related]
10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
11. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
McGeer PL; Schwab C; Parent A; Doudet D
Ann Neurol; 2003 Nov; 54(5):599-604. PubMed ID: 14595649
[TBL] [Abstract][Full Text] [Related]
12. Neurophysiology: stressful pacemaking.
Bean BP
Nature; 2007 Jun; 447(7148):1059-60. PubMed ID: 17597746
[No Abstract] [Full Text] [Related]
13. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic evaluation of the substantia nigra.
McRitchie DA; Halliday GM; Pamphlett R
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):228-32. PubMed ID: 8804024
[TBL] [Abstract][Full Text] [Related]
15. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
[TBL] [Abstract][Full Text] [Related]
16. [Key points in the neuropathological study of idiopathic parkinsonism].
Shiraki H
Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):874-96. PubMed ID: 4897052
[No Abstract] [Full Text] [Related]
17. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of nigral cell death in Parkinson's disease.
Przedborski S
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S3-7. PubMed ID: 15885625
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
